Provided are Echovirus type 25 (ECHO25) or a modified form thereof, or a genomic sequence or cDNA sequence comprising ECHO25 or the modified form thereof, or a nucleic acid molecule of a complement sequence of said genomic sequence or cDNA sequence, use thereof for treating tumors in subjects, and use thereof in preparing a pharmaceutical composition for treating tumors in a subject.